by Suman Gupta
- Indian analytical instrument industry is expected to reach 2.4 billion EUR by 2020
- 100+ exhibitors showcasing technologies of the future
- Over 4000 visitors & 300 Buyer – Seller Meetings
- India Bio Pharma Landscape Conference & Anacon Technology Showcase
April , 2018, Mumbai: Messe Muenchen India organized a regional edition of analytica Anacon India and India Lab Expo, the market leading trade fairs for laboratory technology, analysis, biotechnology and diagnostics. This is the maiden edition which is currently being held in Mumbai from April 25-26, 2018 at the Bombay Exhibition Centre, Goregaon. The expo attracted over 4000 visitors and showcased over 100 national and international exhibitors from Germany, USA, China, Japan and Korea.
The exhibition had a grandeur opening with the presence of eminent industry players like Mr. Satya Chandra Sekhar, Vice President and Head, Reliance Life Sciences, Dr. Reba Chhabra, Deputy Director Quality Control and Head, National Institute of Biologicals, Ministry of Health and Family Welfare, Government of India, Mr. Sampath Srisailam, Senior Group Leader, Syngene International Limited, Dr. Dibyendu Saha, Senior Science, Standards Liaison – Global Biologics, United States Pharmacopeia andMr. Vijay Nag Thota, Deputy General Manager – Biologics Regulatory & Product Strategies, Hetero Drugs and Mr. Bhupinder Singh, CEO, Messe Muenchen India.
The Analytical instrument industry is majorly import driven with 83% share in 2016, expected to come down to 74% by 2020 having CAGR 22% between 2012-2020 with major importing nations like China, USA and Europe, as per a recent report by Euro Asia Consulting.
Indian Analytical instrument consumption is seen in key application sectors such as Pharmaceutical, Biotechnology, Testing, Inspection & Certification industry and Government & Academia. Growth of analytical instruments market largely depends on the performance and R & D spending of industries such as Pharmaceutical, Biotechnology, Chemical and Oil & Gas etc. Life sciences, Food & Beverage are also emerging as prominent sectors which are expected to fuel the market for analytical instruments in the coming years.
Mr. Bhupinder Singh, CEO of Messe Muenchen India said, “Analytical Instruments industry can be made into a robust eco-system by creating competitive positioning through driving sectors’ growth, R & D, local manufacturing focus and government policies. Demand for customized instrumentation from end-user segments such as the pharmaceutical and biotechnology sectors is primarily driving the analytical instruments market in India.”
India remains heavily import dependent (70-80%) to meet Analytical instruments demand, wherein high end equipment are imported, while local manufacturing is limited to basic to medium technology equipment. Analytical instrument industry is evolving with trends such as smart technology adoption, miniaturization, portable instruments and customization; customization being highly demanding by end users. Indian analytical instruments industry is emerging (2 Billion EUR) and has potential opportunities mainly driven by shifting customer focus, foreign player’s footprint and emerging application sectors.
India’s pharmaceutical sector has reformed into a global R&D hub. India’s pharma industry exhibits strong manufacturing and export competencies allowing it to be one of the most competitive regions globally. The growth in Life Sciences, Pharmaceutical Research, Biotechnology, Chemical, Oil & Gas, Food & Beverage industry is fueling the consumption of analytical instrument in India. Indian analytical instrument industry is expected to reach 2.4 billion EUR by 2020 having CAGR of 17% which currently stands at 4% of global market.
The Mumbai Edition of analytica Anacon India and India Lab Expo saw participation from leading companies such as Airtech Corporation, Anatek Services, Chromline Equipment, Genet Bio Co., Hally Instruments, Jiangsu Skyray Solutions Co., Ltd., Japan Analytical Instruments Manufacturers’ Association, S. V. Scientific, United States Pharmacopeia, Art Lab Equipments, Simson Pharma, Waters India Pvt. Ltd. – TA, Instruments Division and Sarstedt AG & Co. KG., Agilent Technologies India Pvt. Ltd., Biolinx Lab Systems Pvt. Ltd., Glassco Laboratories Equipments Pvt. Ltd., Kevi Labtrech, India., Shimadzu Analytical (India) Pvt. Ltd., Simson Pharma, India., Toshvin Analytical Pvt. Ltd., Unichrome Associates, India.
“The analytical industry is one of the smallest segments in India but is one of the most crucial industries. There is a huge opportunity for entrepreneurs to ‘Make in India’. Focus of Food & Drug Administration and Medicine & Healthcare Products Regulatory to improve safety standards. There is a necessity for entrepreneurs, government and organizations to brainstorm and invest in creating the appropriate environment.” further added by Mr. Bhupinder Singh.
Analytical instruments demand to be majorly driven by technological advancement of machines, government funding, FDI in pharma along with stringent regulations resulting in steady growth. 100% FDI under the automatic route in Greenfield pharma and Pharma 2020 vision aims to make India as a global hub for end to end drug discovery.
The event also had a series of conference programs focusing on in-depth discussions on the development, challenges and implementation of quality standards pertaining to bio-pharma process. Renowned speakers from Reliance Life Sciences; National Institute of Biologicals, Ministry of Health and Family Welfare, Government of India; Syngene International Limited; Global Biologics, United States Pharmacopeia; Hetero Drugs delivered key insights.
The flagship edition of the trade fair will continue to take place in Hyderabad and is scheduled for September 6-8, 2018 at HITEX, Hyderabad.
Photo Caption (Left – Right)
- Mr. Vijay Nag Thota, Deputy General Manager – Biologics Regulatory & Product Strategies, Hetero Drugs.
- Mr. Sampath Srisailam, Senior Group Leader, Syngene International Limited
- Dr. Reba Chhabra, Deputy Director Quality Control and Head, National Institute of Biologicals, Ministry of Health and Family Welfare, Government of India.
- Dr. Charu Mehra Kamal, Scientist Grade – II and Head Recombinant Product & Enzyme and Hormone Laboratory, National Institute of Biologicals, Ministry of Health and Family Welfare, Government of India.
- Dr Ashes Ganguly, President, Indian Analytical Instruments Association
- Mr. Bhupinder Singh, CEO, Messe München India
- Mr. Chandrahas Shetty, Managing Director, Skytech Systems Pvt. Ltd.
- Dr. Suhas Rajeeva, Associate Scientific Manager, Biocon
